Stem Cells

The 11th Circuit ruled that it lacks jurisdiction over patients’ appeal to intervene in an action between a corporation running a stem cell “bank” and the U.S. Food and Drug Administration, which sued the bank to prevent it from distributing stem cell products until it obtains approval.

ATLANTA — The 11th Circuit ruled that it lacks jurisdiction over patients’ appeal to intervene in an action between a corporation running a stem cell “bank” and the U.S. Food and Drug Administration, which sued the bank to prevent it from distributing stem cell products until it obtains approval.

Categories / Appeals, Government, Health

Subscribe to Closing Arguments

Sign up for new weekly newsletter Closing Arguments to get the latest about ongoing trials, major litigation and hot cases and rulings in courthouses around the U.S. and the world.

Stem Cells

Subscribe to Closing Arguments

Additional Reads